Exciting Startups: Tute Genomics
WuXi Pharma Tech acquire NextCODE Health to further expand clinical genomics services.
New study publishes important results to improve future treatment of gastric cancer.
Human Longevity will be conducting whole genome sequencing and analysis on Genentech samples.
Roche are planning on spending $1 billion to take majority control of Foundation Medicine.
Illumina step up their healthcare plans with Lockheed Martin collaboration.
Pfizer sign up to 23andMe’s Research Portal. 23andMe planning to announce a total of 10 similar deals this year.
Start up, 10X Genomics, to start offering long-read solution leveraging existing Illumina technology.
Four more conditions have been added to Public Health England’s NHS Newborn Blood Spot Screening Programme.
23andMe & Genentech partner to find new therapeutic targets for Parkinson’s
Claritas Genomics have selected NextCODE Health to help improve their genomic capabilities…..
Blackberry and NantHealth have announced the launch of a clinical genome browser for Blackberry’s Passport device.
University of Chicago and the National Cancer Institute are addressing one of genomics’ biggest bottlenecks.
British citizens now have affordable access to their own genetic information, as 23andMe launch in the UK.
The CHARGE Consortium undertake the largest ever study of the genetics of memory. Meta-analysis reveals genetic variants associated with memory loss.